Erika Hitre

Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer

Eric Van Cutsem, Claus-Henning Köhne, Erika Hitre et al. · New England Journal of Medicine · 2009 · 3.9K citations · Full text

Medicine, Oncology, Pharmacology +17

First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial

Yelena Y. Janjigian, Kohei Shitara, Markus Moehler et al. · The Lancet · 2021 · 2.9K citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98

Sherene Loi, Nicolas Sirtaine, Fanny Piette et al. · Journal of Clinical Oncology · 2013 · 1.6K citations

Medicine, Immunology, Oncology +17

Trastuzumab-Associated Cardiac Adverse Effects in the Herceptin Adjuvant Trial

Thomas Suter, Marion Procter, Dirk J. van Veldhuisen et al. · Journal of Clinical Oncology · 2007 · 565 citations · Full text

Medicine, Cardiology, Oncology +17

Goserelin for Ovarian Protection during Breast-Cancer Adjuvant Chemotherapy

Halle C. F. Moore, Joseph M. Unger, Kelly‐Anne Phillips et al. · New England Journal of Medicine · 2015 · 542 citations · Full text

Medicine, Gynecology, Oncology +16